These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
88 related items for PubMed ID: 21827993
21. [Prevalence of intimal pathogen burden in acute coronary syndromes]. Andrié R, Braun P, Heinrich KW, Lüderitz B, Bauriedel G. Z Kardiol; 2003 Aug; 92(8):641-9. PubMed ID: 12955411 [Abstract] [Full Text] [Related]
22. Co-infection ratios versus inflammation, growth factors and progression of early atheromas. Higuchi ML, Góis JM, Reis MM, Higuchi-Dos-Santos MH, Diament J, Sousa JM, Ramires JA, Oliveira SA. APMIS; 2006 May; 114(5):338-44. PubMed ID: 16725009 [Abstract] [Full Text] [Related]
23. Comparison of nasopharyngeal and throat swabs for the detection of Chlamydia pneumoniae and Mycoplasma pneumoniae by polymerase chain reaction. Gnarpe J, Lundbäck A, Gnarpe H, Sundelöf B. Scand J Infect Dis Suppl; 1997 May; 104():11-2. PubMed ID: 9259072 [Abstract] [Full Text] [Related]
28. [Mycoplasma pneumoniae and Chlamydophila pneumoniae coinfection in severe pneumoniae among a hospitalized child with respiratory distress: what are the best diagnostic tools for an optimal care?]. Petitjean-Lecherbonnier J, Dina J, Gouarin S, Kozisek S, Poveda JD, Vabret A. Pathol Biol (Paris); 2010 Dec; 58(6):434-6. PubMed ID: 19375247 [Abstract] [Full Text] [Related]
30. [The presence of Chlamydophila pneumoniae, Helicobacter pylori and cytomegalovirus in human atherosclerosis detected by molecular and serological methods]. Pinar A, Oç M, Akyön Y, Farsak B, Koçyildirim E, Us D, Zorlutuna Y, Tokgözoğlu L, Böke E. Mikrobiyol Bul; 2004 Jul; 38(3):213-22. PubMed ID: 15490840 [Abstract] [Full Text] [Related]
34. Chlamydia pneumoniae in atherosclerotic and nonatherosclerotic tissue. Ouchi K, Fujii B, Kudo S, Shirai M, Yamashita K, Gondo T, Ishihara T, Ito H, Nakazawa T. J Infect Dis; 2000 Jun; 181 Suppl 3():S441-3. PubMed ID: 10839733 [Abstract] [Full Text] [Related]
35. Matrix metalloproteinase-9 expression is associated with the presence of Chlamydia pneumoniae in human coronary atherosclerotic plaques. Arno G, Kaski JC, Smith DA, Akiyu JP, Hughes SE, Baboonian C. Heart; 2005 Apr; 91(4):521-5. PubMed ID: 15772219 [Abstract] [Full Text] [Related]
36. Effects of atypical pneumonia agents on progression of atherosclerosis and acute coronary syndrome. Iriz E, Cirak MY, Engin ED, Zor MH, Erer D, Imren Y, Turet S, Halit V. Acta Cardiol; 2007 Dec; 62(6):593-8. PubMed ID: 18214125 [Abstract] [Full Text] [Related]
37. Specificity of detection of Chlamydia pneumoniae in cardiovascular atheroma. Jackson LA, Campbell LA, Schmidt RA, Kuo C, Cappuccio AL, Lee MJ, Grayston JT. J Infect Dis; 2000 Jun; 181 Suppl 3():S447-8. PubMed ID: 10839735 [Abstract] [Full Text] [Related]
38. Infectious atherosclerosis: is the hypothesis still alive? A clinically based approach to the dilemma. Alviar CL, Echeverri JG, Jaramillo NI, Figueroa CJ, Cordova JP, Korniyenko A, Suh J, Paniz-Mondolfi A. Med Hypotheses; 2011 Apr; 76(4):517-21. PubMed ID: 21216537 [Abstract] [Full Text] [Related]